A Meta-Analysis and Indirect Comparison of Endothelin A Receptor Antagonist for Castration-Resistant Prostate Cancer

BACKGROUND: Endothelin A (ET-A) receptor antagonists including zibotentan and atrasentan, have been suggested as a treatment for castration-resistant prostate cancer (CRPC). Our aim was to conduct a meta-analysis and indirect comparison to assess the efficacy and safety of ET-A receptor antagonists...

Descripción completa

Detalles Bibliográficos
Autores principales: Qi, Ping, Chen, Ming, Zhang, Li-xiu, Song, Rui-xia, He, Zhen-hua, Wang, Zhi-ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4508042/
https://www.ncbi.nlm.nih.gov/pubmed/26192308
http://dx.doi.org/10.1371/journal.pone.0133803

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4508042/
https://www.ncbi.nlm.nih.gov/pubmed/26192308
http://dx.doi.org/10.1371/journal.pone.0133803

Ejemplares similares